Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-01-31 5:52 pm Sale | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,582,313 6.4% | -185,768![]() (-10.51%) | View |
2022-04-11 4:46 pm Sale | 13D | Bio-Rad Laboratories, Inc. BIO | SCHWARTZ ALICE N | 4,555,452 89.7% | -522![]() (-0.01%) | View |
2022-02-09 3:33 pm Purchase | 13G | Bio-Rad Laboratories, Inc. BIO | VANGUARD GROUP INC | 2,287,465 9.21% | 15,092![]() (+0.66%) | View |
2022-02-09 09:09 am Purchase | 13G | Bio-Rad Laboratories, Inc. BIO | FMR LLC | 1,928,323 7.764% | 236,069![]() (+13.95%) | View |
2022-01-31 5:49 pm Sale | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,768,081 7.1% | -124,255![]() (-6.57%) | View |
2021-02-10 10:39 am Purchase | 13G | Bio-Rad Laboratories, Inc. BIO | VANGUARD GROUP INC | 2,272,373 9.18% | 294,846![]() (+14.91%) | View |
2021-02-08 10:17 am Purchase | 13G | Bio-Rad Laboratories, Inc. BIO | FMR LLC | 1,692,254 6.84% | 1,692,254![]() (New Position) | View |
2021-01-28 5:56 pm Sale | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,892,336 7.6% | -426,716![]() (-18.40%) | View |
2020-02-12 09:26 am Purchase | 13G | Bio-Rad Laboratories, Inc. BIO | VANGUARD GROUP INC | 1,977,527 7.96% | 91,462![]() (+4.85%) | View |
2020-02-05 11:25 am Purchase | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 2,319,052 9.3% | 383,044![]() (+19.79%) | View |
2019-07-12 4:45 pm Purchase | 13D | Bio-Rad Laboratories, Inc. BIO | SCHWARTZ ALICE N | 4,555,974 89.3% | 358![]() (+0.01%) | View |
2019-02-15 10:34 am Sale | 13G | Bio-Rad Laboratories, Inc. BIO | EATON VANCE MANAGEMENT | 0 0% | -1,573,235![]() (Position Closed) | View |
2019-02-11 11:47 am Purchase | 13G | Bio-Rad Laboratories, Inc. BIO | VANGUARD GROUP INC | 1,886,065 7.58% | 162,953![]() (+9.46%) | View |
2019-02-04 10:07 am Purchase | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,936,008 7.8% | 159,298![]() (+8.97%) | View |
2018-02-14 2:09 pm Purchase | 13G | Bio-Rad Laboratories, Inc. BIO | EATON VANCE MANAGEMENT | 1,573,235 6.38% | 1,573,235![]() (New Position) | View |
2018-02-12 12:45 pm Purchase | 13G | Bio-Rad Laboratories, Inc. BIO | VANGUARD GROUP INC | 1,723,112 6.98% | 108,612![]() (+6.73%) | View |